Major pharmacy reforms in Sweden

16 March 2009

Sweden's liberal-conservative government has announced details of the final elements of its comprehensive pharmacy reform program, involving  the shift from a state monopoly in the retailing of prescription and  over-the-counter drugs to a largely privatized and deregulated system by  the end of this year. Some medicines, such as aspirin, will be available  outside pharmacies while pharmacists, who are currently graded as  state-employed clerical staff, are granted flexible terms to take over  the ownership of their stores. Big chains will also be encouraged, with  900 outlets - half of the country's total - offered for sale in packages  of up to 20 pharmacies.

The government, a coalition of the libertarian-conservative Moderate  party, the Christian Democrats and the Liberal People's Party, hopes  that drug prices will be made more competitive. Pharmacies will be  allowed to negotiate discounts with branded and generic drugmakers,  while OTC products are already subject to free pricing.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight